コンテンツにジャンプ
国立がん研究センター 中央病院

トップページ > 共通部門のご案内 > 支持療法開発センター > 業績一覧

業績一覧

2020年

論文

  1. Fujimori M, Sato A, Jinno S, et al. Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial. BMJ Open. 2020 Sep 23;10(9):e036745. [PubMed ]
  2. Zenda S, Ryu A, Takashima A, et al. Hydrocolloid dressing as a prophylactic use for hand–foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study. BMJ Open. 2020 Oct 6;10(10):e038276. [PubMed ]
  3. Fujisawa D, Umemura S, Okizaki A, et al. Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020 Nov 26;10(11):e037759. [PubMed ]
  4. Wada S, Sadahiro R, Matsuoka YJ, et al. Yokukansan for Treatment of Preoperative Anxiety and Prevention of Postoperative Delirium in Cancer Patients Undergoing Highly Invasive Surgery. J-SUPPORT 1605 (ProD Study): A Randomized, Double-Blind, Placebo-Controlled Trial. J Pain Symptom Manage. 12:S0885-3924(20)30601-1 (2020/ in Press). [PubMed ]
  5. Harashima S, Fujimori M. Risk of suicide among adolescents and young adults with cancer and a need for targeted interventions. Ann Transl Med. 2020 Apr;8(7):428. [PubMed ]
  6. Matsuda Y, Tanimukai H, Inoue S, et al. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2020 May 5;50(5):586-593. [PubMed ]
  7. Chen SY, Fujimori M, Wang HM, et al. Gender Differences in Cancer Patients' Preferences for Truth-Telling in Taiwan. Cancer Nurs. 2020 Jul 8. [PubMed ]
  8. Higuchi Y, Fujiwara M, Nakaya N, et al. Trends in smoking rates among individuals with serious psychological distress: Analysis of data from a Japanese national survey, 2007-2016. Psychiatry Res. 2020 Sep;291:113225. [PubMed ]
  9. Fujisawa D, Umezawa S, Fujimori M, et al. Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors. Jpn J Clin Oncol. 2020 Oct 22;50(11):1325-1329. [PubMed ]
  10. Brehaut E, Neupane D, Levis B, et al. Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis. J Psychosom Res. 2020 Dec;139:110256. [PubMed ]

その他

  1. 国立がん研究センター編. がん医療における自殺対策の手引き(2019年度版)
  2. 宮路天平. 臨床試験プロトコールに患者報告アウトカムを組み込むためのガイドライン─SPIRIT-PRO拡張版─. 薬理と治療. 48;(10): 1697-1712. 2020.

2019年

論文

  1. Wada S, Inoguchi H, Sadahiro R, et al. Preoperative Anxiety as a Predictor of Delirium in Cancer Patients: A Prospective Observational Cohort Study. World J Surg. 2019 Jan;43(1):134-142. [PubMed ]
  2. Harashima S, Fujimori M, Akechi T, et al. Suicide, other externally caused injuries and cardiovascular death following a cancer diagnosis: study protocol for a nationwide population-based study in Japan (J-SUPPORT 1902). BMJ Open. 2019 Jul 4;9(7):e030681. [PubMed ]
  3. Mori M, Fujimori M, Ishiki H, et al. Adding a wider range and “hope for the best, and prepare for the worst” statement: Cancer patients’ preferences for prognostic communication. Oncologist. 2019;24:e943-e952. [PubMed ]
  4. Mori M, Fujimori M, Ishiki H, et al. The effects of adding reassurance statements: Cancer patients’ preferences for phrases in end-of-life discussions. J Pain Symptom Manage. 2019;57:1121-1129. [PubMed ]
  5. Mori M*, Fujimori M* (co-primary), van Vliet L, Yamaguchi T, et al. Explicit Prognostic Disclosure to Asian Women With Breast Cancer: A Randomized Scripted Video-Vignette Study (J-SUPPORT1601). Cancer 2019;125:3320-3329. [PubMed ]
  6. Wada S, Sadahiro R, Matsuoka YJ, et al. Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial. Trials. 2019 Feb 8;20(1):110. [PubMed ]
  7. Fujiwara M, Inagaki M, Shimazu T, et al. A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study. BMJ Open. Nov 2;9(11):e032955. 2019. [PubMed ]
  8. Imai F, Momino K, Katsuki F, et al. Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study Jpn J Clin Oncol 49: 537-544, 2019. [PubMed ]
  9. Hashimoto H, Abe M, Tokuyama O, et al. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. THE LANCET ONCOLOGY Published online December 11, 2019 [PubMed ]

その他

2年次知的財産権
特願 2019-017498 
出願日 2019年2月1日 
発明者 明智龍男、山口拓洋
出願人 名古屋市立大学、東北大学
名称 サービス提供支援装置及びプログラム

2018年

論文

  1. Zenda S, Yamaguchi T, Yokota T, et al. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.  BMC cancer. 2018 Sep 6;18(1)873 doi: 10.1186/s12885-018-4763-1.[PubMed ]
  2. Akechi T, Yamaguchi T, Uchida M, et al.  Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention  to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial. BMJ Open. 2018 Nov 8;8(11):e024794.[PubMed ]
  3. Hashimoto H, Abe M, Yanai T, et al. Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy. Jpn J Clin Oncol. 2018 Oct 1;48(10):950-952.doi: 10.1093/jjco/hyy114 [PubMed ]
  4. Shibayama O, Yoshiuchi K, Inagaki M, et al. Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy. Int J Clin Oncol. 2018.[PubMed ]
  5. Yamada Y, Fujimori M, Shirai Y, et al. Changes in Physicians' Intrapersonal Empathy After a Communication Skills Training in Japan. Acad Med. 2018 Dec;93(12):1821-1826.[PubMed ]
  6. Kako J, Morita T, Yamaguchi T, et al. Fan Therapy Is Effective in Relieving Dyspnea in Patients With Terminally Ill Cancer: A Parallel-Arm, Randomized Controlled Trial. J Pain Symptom Manage. 2018 Oct;56(4):493-500.[PubMed ]
  7. Fujiwara M, Inagaki M, Nakaya N, et al. Smoking among adults with serious psychological distress: Analysis of anonymized data from a national cross-sectional survey in Japan. J Affect Disord. 2018 Oct 15;239:131-137. [PubMed ]
  8. Hamano J, Morita T, Mori M, et al. Talking About Palliative Sedation With the Family: Informed Consent vs. Assent and a Better Framework for Explaining Potential Risks. J Pain Symptom Manage. 2018 Sep;56(3):e5-e8. [PubMed ]
  9. Hayashibara C, Inagaki M, Fujimori M, et al. Confidence in communicating with patients with cancer mediates the relationship between rehabilitation therapists' autistic-like traits and perceived difficulty in communication. Palliat Support Care. 2018 Jan 21時1分-9 [PubMed ]
  10. Fujiwara M, Inagaki M, Nakaya N, et al. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan. Cancer. 2018 Feb 1;124(3):555-562.[PubMed ]
  11. Kokubun H, Takigawa C, Miyano K, et al. A novel method for determination of methadone in the serum by high-performance liquid chromatography with electrochemical detection. Biol Pharm Bull, 41 (4): 649-651, 2018. [PubMed ]
  12. Meguro Y, Miyano K, Hirayama S, et al. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. J Pharmacol Sci, 137 (1): 67-75, 2018. [PubMed ]
  13. Miyano K, Nonaka M, Uzu M, et al. Multifunctional actions of Ninjinyoeito, a Japanese kampo medicine: Accumulated scientific evidence based on experiments with cells and animal models, and clinical studies. Front Nutr, 5: 93, 2018. [PubMed ]
  14. Terawaki K, Kashiwase Y, Uzu M, et al. Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85AsZ2 cells in rats. Oncotarget, 9 (78): 34748-34764, 2018. [PubMed ]
  15. Ishiki H, Yamaguchi T, Matsumoto Y, et al. Effect of early palliative care: complex intervention and complex results. Lancet Oncol. 2018; 19(5): e221. [PubMed ]
  16. 全田貞幹. 支持療法に関する臨床研究グループ(J-SUPPORT)頭頸部癌 44(3):276-279. 2018年10月.

その他

1. 「支持療法・緩和治療領域研究ポリシー(総論)」公開について, 国立がん研究センター・日本医療研究開発機構[AMED]との連名でプレスリリース, 2018年12月
2. 「支持療法・緩和治療領域研究ポリシー(総論)Ver.1.0」 国立がん研究センター中央病院支持療法開発部門ホームページ上で公開 2018年12月

2017年

論文

  1. Fujimori M, Akechi T, Uchitomi Y. Factors associated with patient preferences for communication of bad news. Palliat Support Care. 2017 Jun;15(3):328-335. [PubMed ]
  2. Fujiwara M, Inagaki M, Nakaya N, et al. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan. Cancer. 2017. [PubMed ]
  3. Fujiwara M, Inagaki M, Nakaya N, et al. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017. [PubMed ]
  4. Higuchi Y, Inagaki M, Koyama T, et al. Emotional Intelligence and its Effect on Pharmacists and Pharmacy Students with Autistic-like Traits. Am J Pharm Educ. 2017; 81(4): 74. [PubMed ]
  5. Kako J, Morita T, Yamaguchi T, et al. Evaluation of the Appropriate Washout Period Following Fan Therapy for Dyspnea in Patients With Advanced Cancer: A Pilot Study. Am J Hosp Palliat Care. 2017. [PubMed ]

2016年

論文

  1. Zenda S, Ota Y, Tachibana H, et al. A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients. J Radiat Res. 2016 ; 57(3): 301-6. [PubMed ]
  2. Inoguchi H, Shimizu K, Shimoda H, et al. Screening for untreated depression in cancer patients: a Japanese experience. Jpn J Clin Oncol. 2016 Nov 1;46(11):993-999. [PubMed ]
  3. Fujiwara M, Inagaki M, Higuchi Y, et al. An Open-Label Feasibility Trial of Repetitive ranscranial Magnetic Stimulation for Treatment-Resistant Major Depressive Episodes. Acta Med Okayama. 2016; 70(4): 307-11. [PubMed ]
  4. Higuchi Y, Inagaki M, Koyama T, et al. A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan. BMC Public Health. 2016; 16: 534. [PubMed ]